Do not miss this presentation EGFR Resisters EGFRm NSCLC #lungcancer #lcsm

Sometimes new agents dont have a better OS but at least if they provide a benefit like PFS and the toxicity profile its better, those are good benefits for our patients instead of using a 25 year old agent!lets see the data Lung Ambition Alliance LUNGevity Foundation GO2 for Lung Cancer #lungcancer

Kudos for Grupo Español de Cáncer de Pulmón and M.Provencio that were the first to show that theres benefit adding adjuvant IO after Neoadjuvant IO in the NADIM II #lungcancer #lcsm #immunotherapy

Dato-did doesn’t improve OS in overall study pop vs docetaxel but does in non-sq subgroup. Key decision for FDA Oncology - is a subgroup analysis sufficient to support an approval? My guess is yes but w post marketing requirement for a non-sq trial, #lcsm astrazeneca.com/media-centre/p…

#lungcancer #lcsm

Well done Merouane Messekher Julien Mazieres we really need to interrogate tumors again after treatment failure as standard of care otherwise patients wont benefit! EGFR Resisters EGFRm NSCLC EGFR Positive UK #lungcancer #lcsm

#lungcancer #lcsm we are in need of biomarkers to predict recurrence in early stage!

All the best for the ISLB family, an amazing night with our speakers. International Society of Liquid Biopsy ELO Umberto Malapelle VCDenninghoff David Gandara Christian Rolfo GENYO Rosario Sanchez UGR Evi Giannakakou Massimo Cristofanilli, MD, FACP

#ASCO24 ASCO great meeting for #lungcancer developments this year #lcsm

Great results for perioperative #immunotherapy #lungcancer #lcsm

🤩🔥Delighted to share our editorial with this stellar team, talking about the role of liquid biopsy in the sustained progression of precision oncology. Also highlighted in the presentation by our committee chair Carolina Reduzzi today at the International Society of Liquid Biopsy 20th year anniversary

🚀 Excited to be at #ASCO2024 ! Visit us at booth 10027 to learn more about the International Society of Liquid Biopsy (ISLB) and our latest advancements. See you there! #LiquidBiopsy #CancerResearch #ISLB #ASCO2024

🎉 Celebrating the 20th Anniversary of the first publication on Circulating Tumor Cells! 📖🔬 Stay tuned for photos and highlights as we look back on two decades of groundbreaking research and progress. #CTC20Years #CancerResearch #MedicalMilestone

Dr Pierga inagurates the CTC Symposium in Granada. Umberto Malapelle International Society of Liquid Biopsy ELO Christian Rolfo David Gandara GENYO

Great news for our patients, liquid biopsies moving to front line therapy International Society of Liquid Biopsy

Homework before #ASCO24 - have you checked this year’s #ASCOEdBook ?
ASCO

ascopubs.org/toc/edbk/curre…

Our 2024 Memorial Cancer Institute Memorial Healthcare System Moffitt Cancer Center Florida Atlantic University Best of ASCO is coming soon! July12-13th at the JW Marriott Hotels Marquis in Miami #lungcancer #lcsm with 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Christian Rolfo Edgardo S. Santos, M.D., FACP, FASCO Aurelio B. Castrellón Bruna Pellini, MD Manmeet Ahluwalia, MD, MBA, FASCO Jose Sandoval S, MD FACP 🇨🇴🇨🇴 Dr. Nagla Abdel Karim

It is a great honor to be one of the speakers for Best of ASCO Memorial Cancer Institute #Miami Thank you Dr. Luis E. Raez for the invitation.

Our 2024 Memorial Cancer Institute Memorial Healthcare System Moffitt Cancer Center Florida Atlantic University Best of ASCO is coming soon! July12-13th at the JW Marriott Hotels Marquis in Miami #lungcancer #lcsm with 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Christian Rolfo Edgardo S. Santos, M.D., FACP, FASCO Aurelio B. Castrellón Bruna Pellini, MD Manmeet Ahluwalia, MD, MBA, FASCO Jose Sandoval S, MD FACP 🇨🇴🇨🇴 Dr. Nagla Abdel Karim